OSEL Devices Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Guidance rank: #1 of 13 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Based on OSEL Devices Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from Sales and Services for the half year ended 30.09.2026: Rs. 19,363.37 lakhs (consolidated), Rs. 18,322.77 lakhs (standalone). EBITDA for the half year ended September 30, 2026 is Rs. 2,492.01 lakhs (Standalone, calculated as Profit before Exceptional Items, Tax, Depreciation & Finance Costs: Rs. 2,495.98 lakhs - Finance Cost.
From OSEL Devices Ltd's Q2 FY27 earnings-call transcript · updated 12 Nov 2026.
How did OSEL Devices' revenue grow in the September 2026 quarter?
- Revenue from Sales and Services for the half year ended 30.09.2026: Rs. 19,363.37 lakhs (consolidated), Rs. 18,322.77 lakhs (standalone).
- For the corresponding previous half year (30.09.2025): Rs. 14,686.13 lakhs.
- Year-on-year revenue growth (consolidated): approx. 31.8% increase ((19,363.37 - 14,686.13)/14,686.13).
2 more points from OSEL Devices Ltd's call on revenue
Create a free account to keep reading this call
What happened to OSEL Devices' margins in Q2 FY27?
See what OSEL Devices Ltd said on profitability & margins — free account, 30 seconds.
What capex is OSEL Devices planning?
- The primary mentions of fund utilization relate to:
- - Rs. 2.55 crore raised through Preferential Issue of Fully Convertible Warrants dated 23-04-2026, used fully to meet additional working capital requirements.
- - Rs. 70.65 crore raised through Initial Public Offer on 20-09-2024, utilized mainly for repayment of loans (Rs. 6 crore), funding working capital (Rs. 44 crore), and general corporate purposes (approx. Rs. 10.75 crore unutilized).
- Capital expenditures reported in cash flow statements include purchase of fixed assets (~Rs. 13.71 lakh standalone, Rs.
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is OSEL Devices raising money or cutting debt?
See what OSEL Devices Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is OSEL Devices' order book?
See what OSEL Devices Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Healthcare Equipment & Supplies
- Poly Medicure Q2 FY27 results
- Molbio Diagnosti Q2 FY27 results
- Sahajanand Medi Q2 FY27 results
- Tarsons Products Q2 FY27 results
- Laxmi Dental Q2 FY27 results
- Vasa Denticity Q2 FY27 results
- Nureca Q2 FY27 results
- Vaidya Sane Q2 FY27 results
All Q2 FY27 results | Healthcare Equipment & Supplies rankings
Continue your research
What OSEL Devices's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Tarsons Products (Q2 FY27)
Revenue from operations for the quarter ended September 30, 2026: ₹1,002.32 million (Standalone), ₹1,236.50 million (Consolidated). Key investor presentation ta
- Avience Biomedicals (Q2 FY27)
430.93 Lakhs or approximately 16.07%. Key results statement takeaways from Avience Biomedicals Ltd's Q2 FY27 results statement — and how it ranks against sector
- Vasa Denticity (Q2 FY27)
Growth levers prioritize increasing average revenue per user (ARPU) rather than just increasing order volume or average order value (AOV), which still has room…
- Vaidya Sane (Q2 FY27)
Year-on-year (YoY) change: +23% (from INR 687 Lakhs in Sep 2025) . Key results statement takeaways from Vaidya Sane Ayurved Laboratories Ltd's Q2 FY27 results s
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- 1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
OSEL Devices Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were OSEL Devices Ltd Q2 FY27 results?
Revenue from Sales and Services for the half year ended 30.09.2026: Rs. 19,363.37 lakhs (consolidated), Rs. 18,322.77 lakhs (standalone). EBITDA for the half year ended September 30, 2026 is Rs. 2,492.01 lakhs (Standalone, calculated as Profit before Exceptional Items, Tax, Depreciation & Finance Costs: Rs. 2,495.98 lakhs - Finance Cost.
What is OSEL Devices Ltd share price analysis?
OSEL Devices Ltd currently shows a neutral. The stock trades at a P/E of 23.6 with a market cap of ₹690 Cr. Investors should review the full earnings analysis for detailed insights.
Keep OSEL Devices Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.